You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR NEBCIN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NEBCIN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03066453 ↗ Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis Terminated University Hospital, Lille Phase 3 2017-06-13 The aim of this study is to investigate the efficacy of antibiotic therapy with any antibiotic (IV) and IV (Nebcin®) tobramycin for 5 days followed by Solution for nebuliser inhalation (Tobi®) for 9 days and antibiotic cures using 14 days of tobramycin IV. In the case of positive results, the reduction of the duration of IV treatment of tobramycin from 14 days to 5 days would limit the risk of toxicity.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NEBCIN

Condition Name

Condition Name for NEBCIN
Intervention Trials
Cystic Fibrosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NEBCIN
Intervention Trials
Fibrosis 1
Cystic Fibrosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NEBCIN

Trials by Country

Trials by Country for NEBCIN
Location Trials
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NEBCIN

Clinical Trial Phase

Clinical Trial Phase for NEBCIN
Clinical Trial Phase Trials
Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NEBCIN
Clinical Trial Phase Trials
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NEBCIN

Sponsor Name

Sponsor Name for NEBCIN
Sponsor Trials
University Hospital, Lille 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NEBCIN
Sponsor Trials
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.